Tsuyoshi Takahara : Citation Profile

Senshu University

1

H index

0

i10 index

2

Citations

RESEARCH PRODUCTION:

3

Articles

6

Papers

RESEARCH ACTIVITY:

   11 years (2013 - 2024). See details.
   Cites by year: 0
   Journals where Tsuyoshi Takahara has often published
   Relations with other researchers
   Recent citing documents: 1.    Total self citations: 0 (0 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/pta527
   Updated: 2025-12-13    RAS profile: 2025-10-11    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers

Works with:

Ishida, Junichiro (2)

Authors registered in RePEc who have co-authored more than one work in the last five years with Tsuyoshi Takahara.

Is cited by:

LEVAGGI, ROSELLA (2)

Cites to:

Matsumura, Toshihiro (6)

LELEU, Hervé (3)

Crainich, David (3)

Ellis, Randall (3)

Sloan, Frank (3)

Matsushima, Noriaki (3)

Mauleon, Ana (3)

Hattori, Keisuke (2)

Lee, Sang-Ho (2)

Holmstrom, Bengt (2)

Haraguchi, Junichi (2)

Main data

Where Tsuyoshi Takahara has published?

Working Papers Series with more than one paper published# docs
ISER Discussion Paper / Institute of Social and Economic Research, The University of Osaka4
MPRA Paper / University Library of Munich, Germany2

Recent works citing Tsuyoshi Takahara (2025 and 2024)

YearTitle of citing document
2024Spatial Competition Models in Health Care Markets: A Review. (2024). LEVAGGI, ROSELLA. In: Review of Industrial Organization. RePEc:kap:revind:v:65:y:2024:i:3:d:10.1007_s11151-024-09978-6.

Full description at Econpapers || Download paper

Works by Tsuyoshi Takahara:

YearTitleTypeCited
2024Should product‐specific advertisement be regulated in pharmaceutical markets? In: Journal of Public Economic Theory.
[Full Text][Citation analysis]		article0
2022Should Product-Specific Advertisement be Regulated in Pharmaceutical Markets?.(2022) In: ISER Discussion Paper.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 0		paper
2013Patient Dumping, Outlier Payment, and Optimal Healthcare Payment Policy under Asymmetric Information In: ISER Discussion Paper.
[Full Text][Citation analysis]		paper0
2014Patient Dumping, Outlier Payments, and Optimal Healthcare Payment Policy under Asymmetric Information.(2014) In: ISER Discussion Paper.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 0		paper
2016Patient dumping, outlier payments, and optimal healthcare payment policy under asymmetric information.(2016) In: Health Economics Review.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 0		article
2019Advertising Regulations in Pharmaceutical Markets: Product Versus Enlightenment In: ISER Discussion Paper.
[Full Text][Citation analysis]		paper0
2022Quality competition, location choice, and ownership conversion in the healthcare market In: Economic Modelling.
[Full Text][Citation analysis]		article2
2023Designing the report card content for healthcare payment reduction In: MPRA Paper.
[Full Text][Citation analysis]		paper0
2024Evaluating Policy Interventions for Audit Quality Improvement: Market Competition versus Audit Firm Separation In: MPRA Paper.
[Full Text][Citation analysis]		paper0

CitEc is a RePEc service, providing citation data for Economics since 2001. Last updated November, 20 2025. Contact: CitEc Team